Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer

Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer

ObjectiveThe current clinical data regarding the re-administration of PARPi maintenance therapy in platinum sensitive recurrent ovarian cancer (PSROC) is limited. This study aims to investigate the efficacy and associated factors of PARPi re-maintenance therapy in PSROC patients in China.MethodsIn t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yulin Wang, Yunjie Yang, Binghong Guo, Xiaoyan Li, Renakezi Tuersun, Ye Cao, Jundong Li, Jihong Liu, Su Li, Tao Liu, Yongwen Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
recurrent ovarian cancer
PARP inhibitors
re-maintenance therapy
prognosis
structural domains of BRCA mutations
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1512339/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1512339/full

Similar Items